Post by Symeres

We are excited to welcome Russell Thomas, Ph.D., who joins Symeres as Chief Scientific Officer (CSO) Officer to drive a joint collaboration between Symeres and Axxam that combines the unique R&D services offering of both organizations. By bringing together the complementary capabilities of both organizations, customers can receive support across integrated discovery and development programs. The integrated solutions offered span all the way from target assessment, screening and testing, lead identification and optimization all the way to development candidate nomination and IND ready packages. “Returning as Chief Scientific Officer feels very exciting as it connects two parts of a story. Having spent important parts of my career at both Symeres and Axxam, I’m excited to help bring together expert led complementary science, strong transatlantic teams and a shared mindset to support partners and projects in a truly integrated way,” said Thomas. Henning Steinhagen, PhD, MBA, CEO Symeres added “As customer programs become more complex, scientific leadership that can connect capabilities, people and platforms across organizations becomes increasingly important. Russell brings a rare combination of scientific expertise, industry experience and first-hand knowledge of both Symeres and Axxam, together with a strong understanding of how to translate early discovery projects into preclinical development and beyond." “Russell’s appointment is aligned to the vision of integrated discovery and development linking two organizations that know each other well. The common objective is to develop faster and better drugs for the pharmaceutical industry and ultimately improve patient’s lives” said Ciriaco Maraschiello, CEO of Axxam. You can read the full release here 🔗https://lnkd.in/eSvrPWAg #DrugDiscovery #Collaboration #DrugDevelopment